Malaria Consortium's seasonal malaria chemoprevention (SMC) programme distributes preventative antimalarial drugs to young children during times of peak malaria transmission.
Malaria kills around 400,000 people each year, the majority of whom are children under 5. Malaria Consortium reports that malaria, a preventable and treatable disease, threatens 3.2 billion people globally.
Malaria Consortium’s mission is “to improve lives in Africa and Asia through sustainable, evidence-based programmes that combat targeted diseases and promote child and maternal health.”
Malaria Consortium fights malaria and other diseases through a variety of strategies and programmes. Its seasonal malaria chemoprevention (SMC) programme distributes preventative antimalarial drugs to young children during times of peak malaria transmission.
Through its SMC programme, Malaria Consortium:
Malaria Consortium’s SMC programme meets our criteria to be top-rated because one of our trusted evaluators, GiveWell, has conducted an extensive evaluation highlighting its cost-effectiveness. (Our trusted evaluators are charitable giving experts who focus on impact — their research into the best charities means your donations can do even more good. Learn more about charity evaluators we trust and why.)
GiveWell estimates that the cost of protecting one child from malaria through this program is about $7 — $1.66 for one of (typically) four monthly treatments. Malaria Consortium has been a GiveWell top charity since 2016.
Your donations through our portal are tax deductible in the UK, US, and the Netherlands. Giving What We Can does not take any fees from donors using our platform or from charities listed on our platform. We are independently funded to promote our mission of making giving effectively and significantly a cultural norm. Read more on our transparency page.